Throughout 2022, clinical research leaders have expressed concerns about the economic and public health challenges that result from slow drug development. After fast-tracked COVID-19 therapies proved development can be accelerated, the status quo is being challenged....
The global life sciences industry has much to learn to bridge the diversity divide in cancer clinical trial participation. The good news is advanced technology can help—it’s time to leverage such modern innovations as artificial intelligence (AI), digital tools, and analytics software to move the...
A recap of human research protections and ethics for clinical research professionals....
Clinical Trials Arena reviews the companies and countries that mentioned decentralization most often in their clinical trial protocols....
New chancellor Jennifer L. Mnookin crafts a "collective vision" for the university's future....
Research programs and studies that are built on a DEI foundation will inevitably have a positive influence on the trajectory of goals that include increasing diversity in clinical trials and cultivating inclusive environments for the biomedical research workforce....
The University of Wisconsin–Madison ranks eighth in national research rankings for public and private universities and increased research expenditures across all fields....
A strong shift to decentralized clinical trials, regulatory changes, and an increased focus on diversity were among the main industry talking points in 2022....
As the tolerance bar for excluding clinical trials participants on the grounds of race and sex lowers significantly, exclusion based on cognitive disability still goes on....
Children who participate in clinical trials can help provide researchers with information adults cannot....
